Format

Send to

Choose Destination
Psychiatry Clin Neurosci. 2015 Jun;69(6):321-34. doi: 10.1111/pcn.12270. Epub 2015 Feb 9.

Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.

Author information

1
Faculty of Medicine, Bar-Ilan University, Tsfat, Israel.
2
Be'er-Sheva Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel.

Abstract

Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking psychotropic drugs. The pathophysiology of tardive dyskinesia is complex, multifactorial and still not fully understood. A number of drugs were tried for the management of this motor disturbance, yet until now no effective and standard treatment has been found. It is very disappointing to realize that the introduction of antipsychotics from the second generation has not significantly decreased the prevalence and incidence of tardive dyskinesia. Therefore, the management of this motor disturbance remains an actual topic as well as a challenge for clinicians. This review summarizes recent relevant publications concerning the treatment of tardive dyskinesia.

KEYWORDS:

first-generation agents; management; schizophrenia; second-generation agents; tardive dyskinesia

PMID:
25556809
DOI:
10.1111/pcn.12270
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center